Santen
Text Size
Listen
Santen USA
  • Patients
  • Healthcare Professionals
  • Careers
  • Investors
Listen

Tap on the left to use.

  • Who We Are
    Core Principle / Our Commitment
    Core Principle / Our Commitment
    Our Values
    Our Values
    Corporate Compliance
    Corporate Compliance
    Company Information
    Santen USA
    Corporate Story
    Corporate Story
  • What We Do
    Santen 2030
    Santen 2030
    Research & Development
    Global Research & Development
    Glaucoma
    Corneal Disorders
    Refractive Disorders
    US Ophthalmic Pipeline and Clinical Trials
    Investigator-Sponsored Trials
    ​​US Product
    FLAREX®
    FRESHKOTE®
    NATACYN®
    TOBRADEX® ST
    Verkazia®
    ZERVIATE®
    Partnering
    Corporate Venture​
    Business Development​
    Partner with Us
  • Our Stories
  • Sustainability
  • News
    News
    News Releases​
    News Archive
  1. Home
  2. News Releases
  3. 2016

2016 News

Stay up to date on all that’s happening at Santen USA. For our global headquarters news, visit Santen Worldwide.

News

11.28.2016 Santen Announces Phase III SAKURA Program Topline Results in Patients with Non-Infectious Uveitis of the Posterior Segment
07.19.2016 Santen to Acquire InnFocus, Developer of “MicroShunt” Glaucoma Implant Device
News Archive

  • Sitemap
  • Terms of Use
  • Privacy Policy
  • Patient Copay Program
  • Contact
Copyright © 2023 Santen Pharmaceutical Co., Ltd.
All Rights Reserved